Shares of LHC Group (NASDAQ:LHCG) have been assigned a consensus rating of “Buy” from the eleven research firms that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $76.67.
A number of analysts recently weighed in on LHCG shares. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $75.00 price target on shares of LHC Group in a research report on Friday, November 3rd. Royal Bank Of Canada upped their price target on shares of LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 7th. Oppenheimer Holdings, Inc. upped their price target on shares of LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 7th. Zacks Investment Research cut shares of LHC Group from a “buy” rating to a “hold” rating in a research report on Wednesday, October 4th. Finally, Bank of America Corporation initiated coverage on shares of LHC Group in a research report on Monday, August 21st. They issued a “buy” rating and a $76.00 price objective for the company.
COPYRIGHT VIOLATION NOTICE: This news story was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://stocknewstimes.com/2017/11/18/brokerages-set-lhc-group-lhcg-pt-at-76-11.html.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.34, for a total value of $173,151.00. Following the sale, the chief operating officer now owns 109,235 shares in the company, valued at approximately $7,137,414.90. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 14.80% of the company’s stock.
Several institutional investors have recently modified their holdings of the company. Alps Advisors Inc. raised its stake in shares of LHC Group by 0.3% in the 2nd quarter. Alps Advisors Inc. now owns 9,449 shares of the health services provider’s stock valued at $641,000 after purchasing an additional 24 shares in the last quarter. Federated Investors Inc. PA raised its stake in shares of LHC Group by 4.2% in the 2nd quarter. Federated Investors Inc. PA now owns 1,622 shares of the health services provider’s stock valued at $110,000 after purchasing an additional 66 shares in the last quarter. Arizona State Retirement System raised its stake in shares of LHC Group by 1.3% in the 2nd quarter. Arizona State Retirement System now owns 7,818 shares of the health services provider’s stock valued at $531,000 after purchasing an additional 100 shares in the last quarter. Victory Capital Management Inc. raised its stake in shares of LHC Group by 0.3% in the 2nd quarter. Victory Capital Management Inc. now owns 48,920 shares of the health services provider’s stock valued at $3,321,000 after purchasing an additional 142 shares in the last quarter. Finally, Texas Permanent School Fund raised its stake in shares of LHC Group by 1.4% in the 2nd quarter. Texas Permanent School Fund now owns 10,944 shares of the health services provider’s stock valued at $743,000 after purchasing an additional 153 shares in the last quarter. Institutional investors and hedge funds own 87.29% of the company’s stock.
Shares of LHC Group (NASDAQ:LHCG) traded down $0.28 during trading on Friday, reaching $67.65. 383,356 shares of the company were exchanged, compared to its average volume of 141,066. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a 12-month low of $41.66 and a 12-month high of $76.14. The stock has a market cap of $1,240.00, a PE ratio of 29.52, a price-to-earnings-growth ratio of 2.04 and a beta of 0.70.
LHC Group (NASDAQ:LHCG) last announced its quarterly earnings results on Monday, November 6th. The health services provider reported $0.64 earnings per share for the quarter, topping analysts’ consensus estimates of $0.60 by $0.04. LHC Group had a net margin of 4.09% and a return on equity of 9.52%. The firm had revenue of $272.90 million during the quarter, compared to analysts’ expectations of $265.35 million. During the same period in the prior year, the company earned $0.54 EPS. The firm’s revenue was up 18.2% on a year-over-year basis. analysts predict that LHC Group will post 2.4 earnings per share for the current year.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.